Mannkind (MNKD) EBT Margin Growth (1y) (2017 - 2026)
Mannkind (MNKD) EBT Margin Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Mannkind |
1.21 Bn |
1.08 Bn |
82.66 Mn |
-3,553.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-3,553.00 |
| Dec 31, 2025 |
-2,970.00 |
| Sep 30, 2025 |
-889.00 |
| Jun 30, 2025 |
356.00 |
| Mar 31, 2025 |
94.00 |
| Dec 31, 2024 |
593.00 |
| Sep 30, 2024 |
1,501.00 |
| Jun 30, 2024 |
849.00 |
| Mar 31, 2024 |
4,055.00 |
| Dec 31, 2023 |
5,484.00 |
| Sep 30, 2023 |
4,732.00 |
| Jun 30, 2023 |
966,350.00 |
| Mar 31, 2023 |
19,268.00 |
| Dec 31, 2022 |
17,445.00 |
| Sep 30, 2022 |
-2,404.00 |
| Jun 30, 2022 |
-952,174.00 |
| Mar 31, 2022 |
-14,272.00 |
| Dec 31, 2021 |
-8,102.00 |
| Sep 30, 2021 |
5,481.00 |
| Jun 30, 2021 |
497,341.00 |
